Bioengineered Immunocompetent Preclinical Trial-on-Chip Tool Enables Screening of CAR T Cell Therapy for Leukemia

Scientists engineered an organotypic immunocompetent chip that recapitulates microarchitectural and pathophysiological characteristics of human leukemia bone marrow stromal and immune niches for CAR T cell therapy modeling.